Terminated EARLY_PHASE1 INTERVENTIONAL 1-arm NCT03067974

Intranasal Ketamine for Pediatric Procedural Sedation: a Feasibility Study

Sponsor: University of Arizona

Conditions Failed Moderate Sedation During Procedure Ketamine Adverse Reaction

Updated 8 times since 2017 Last updated: Jan 24, 2019 Started: Sep 21, 2017 Primary completion: Jan 22, 2019 Completion: Jan 22, 2019

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Initial results did not show benefit.

Other terminated trials from University of Arizona

See all terminations from University of Arizona

This EARLY_PHASE1 trial investigates Failed Moderate Sedation During Procedure and Ketamine Adverse Reaction and is currently terminated or withdrawn. University of Arizona leads this study, which shows 8 recorded versions since 2017 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Terminated EARLY_PHASE1
Jul 2024 — Sep 2024 [monthly]

Terminated EARLY_PHASE1
Jan 2021 — Jul 2024 [monthly]

Terminated EARLY_PHASE1
Feb 2019 — Jan 2021 [monthly]

Terminated EARLY_PHASE1

Status: Recruiting → Terminated
Jun 2018 — Feb 2019 [monthly]

Recruiting EARLY_PHASE1

▶ Show 3 earlier versions

Nov 2017 — Jun 2018 [monthly]

Recruiting EARLY_PHASE1

Status: Not Yet Recruiting → Recruiting
Sep 2017 — Nov 2017 [monthly]

Not Yet Recruiting EARLY_PHASE1
May 2017 — Sep 2017 [monthly]

Not Yet Recruiting EARLY_PHASE1

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University of Arizona

Data source: University of Arizona

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Tucson, United States